Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
12,683
datasets available to search
ShareScore release 0.9.0
Dataset results
12,683 results for “tolerability”
Safety, Tolerability and Efficacy of 28-day Inhaled CHF 6001 DPI in COPD Patients
ClinicalTrials.gov study NCT01730404. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
ClinicalTrials.gov study NCT07223047. IPD Sharing: YES. Countries: 3. Publications: 0.
Tolerability of a Novel Spectacle Design With Reduced Peripheral Contrast
ClinicalTrials.gov study NCT03761758. IPD Sharing: NO. Countries: 1. Publications: 0.
Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1
ClinicalTrials.gov study NCT04156685. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
ClinicalTrials.gov study NCT04477343. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Tolerability of NTX-101 in Korean Healthy Volunteers
ClinicalTrials.gov study NCT05041543. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients
ClinicalTrials.gov study NCT03162874. IPD Sharing: Not stated. Countries: 6. Publications: 0.
A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.
ClinicalTrials.gov study NCT01458197. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Single and Multiple Ascending Dose Study to Assess the Safety, Tolerability and PK of ONO-2910 in Japanese and Caucasian Subjects
ClinicalTrials.gov study NCT04504760. IPD Sharing: NO. Countries: 1. Publications: 0.
DDI Study of ASC41 in HV and the PK, Safety and Tolerability in Subjects With NAFLD.
ClinicalTrials.gov study NCT04845646. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Safety, Tolerability and Pharmacokinetics Study of ZB001 in Healthy Subjects
ClinicalTrials.gov study NCT05542303. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults
ClinicalTrials.gov study NCT03712241. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination
ClinicalTrials.gov study NCT06478537. IPD Sharing: Not stated. Countries: 1. Publications: 0.
AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce
ClinicalTrials.gov study NCT05216172. IPD Sharing: YES. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Tolerability of FX301 in Patients Undergoing Bunionectomy
ClinicalTrials.gov study NCT04826328. IPD Sharing: Not stated. Countries: 1. Publications: 0.
First Time in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food of Single Assending Doses of GSK1482160.
ClinicalTrials.gov study NCT00849134. IPD Sharing: YES. Countries: 1. Publications: 0.
Single Dose Study to Assess the Safety, Tolerability and Pharmacokinetics(PK) of PF-06865571
ClinicalTrials.gov study NCT03092232. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Sitagliptin in Impaired Glucose Tolerance
ClinicalTrials.gov study NCT00961363. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Snack Study: The Feasibility of Changing Night-time Food Choices to Improve Glucose Tolerance in Pregnancy
ClinicalTrials.gov study NCT02634593. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea
ClinicalTrials.gov study NCT00327626. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.